|Mr. Daniel S. Goldberger||CEO & Director||919.64k||N/A||1959|
|Mr. Joseph P. Errico||Co-Founder, Principal Investor & Director||N/A||N/A||1969|
|Mr. Brian M. Posner||CFO & Corp. Sec.||601.62k||N/A||1962|
|Mr. Michael Romaniw||Exec. VP of Systems & Operations||N/A||N/A||1957|
|Ms. Jackie Dorsky||VP of Marketing||N/A||N/A||N/A|
|Mr. Iain Strickland Ph.D.||VP of Global Sales & Strategy||N/A||N/A||N/A|
|Ms. Carrie Kochek||Sr. Director of HR||N/A||N/A||N/A|
|Dr. Peter S. Staats M.B.A., M.D.||Chief Medical Officer||N/A||N/A||1963|
|Mr. Eric J. Liebler||Sr. VP of Neurology||N/A||N/A||1964|
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld delivery system for multi-year use prescribed on a monthly basis. The company was founded in 2005 and is headquartered in Rockaway, New Jersey.
electroCore, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.